Literature DB >> 10982482

Genetic heterogeneity in Noonan syndrome: evidence for an autosomal recessive form.

I van Der Burgt1, H Brunner.   

Abstract

Most Noonan syndrome (NS) families are compatible with autosomal dominant inheritance with predominance of maternal transmission. Sporadic patients can be explained by new autosomal dominant mutations. Here we report four Dutch NS patients, two male and two female, each with unaffected consanguineous parents. All four had a typical NS phenotype and presented with hypertrophic obstructive cardiomyopathy (HOCM) at birth. In two cases the HOCM improved, in one case it deteriorated, and in one case it remained constant over 12 years. These patients support the existence of an autosomal recessive form of NS in which HOCM is more frequent than in autosomal dominant NS. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10982482     DOI: 10.1002/1096-8628(20000904)94:1<46::aid-ajmg10>3.0.co;2-i

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

2.  PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.

Authors:  Marco Tartaglia; Kamini Kalidas; Adam Shaw; Xiaoling Song; Dan L Musat; Ineke van der Burgt; Han G Brunner; Débora R Bertola; Andrew Crosby; Andra Ion; Raju S Kucherlapati; Steve Jeffery; Michael A Patton; Bruce D Gelb
Journal:  Am J Hum Genet       Date:  2002-05-01       Impact factor: 11.025

3.  Noonan syndrome in a premature infant with hypertrophic cardiomyopathy and death in infancy.

Authors:  William Gibson; Cynthia Trevenen; Michael Giuffre; Alexander K C Leung
Journal:  J Natl Med Assoc       Date:  2005-06       Impact factor: 1.798

4.  GNAI2 and regulators of G protein signaling as a potential Noonan syndrome mechanism.

Authors:  Xinyan Huang; Ying Fu; Raelene A Charbeneau; Richard R Neubig
Journal:  Med Hypotheses       Date:  2009-03-17       Impact factor: 1.538

Review 5.  Noonan syndrome.

Authors:  Ineke van der Burgt
Journal:  Orphanet J Rare Dis       Date:  2007-01-14       Impact factor: 4.123

Review 6.  An unexpected new role of mutant Ras: perturbation of human embryonic development.

Authors:  Christian P Kratz; Charlotte M Niemeyer; Martin Zenker
Journal:  J Mol Med (Berl)       Date:  2007-01-09       Impact factor: 4.599

7.  Noonan syndrome - a new survey.

Authors:  Alireza Tafazoli; Peyman Eshraghi; Zahra Kamel Koleti; Mohammadreza Abbaszadegan
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

8.  Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome.

Authors:  Alistair T Pagnamenta; Pamela J Kaisaki; Fenella Bennett; Emma Burkitt-Wright; Hilary C Martin; Matteo P Ferla; John M Taylor; Lianne Gompertz; Nayana Lahiri; Katrina Tatton-Brown; Ruth Newbury-Ecob; Alex Henderson; Shelagh Joss; Astrid Weber; Jenny Carmichael; Peter D Turnpenny; Shane McKee; Francesca Forzano; Tazeen Ashraf; Kimberley Bradbury; Deborah Shears; Usha Kini; Anna de Burca; Edward Blair; Jenny C Taylor; Helen Stewart
Journal:  Clin Genet       Date:  2019-04-03       Impact factor: 4.438

Review 9.  The RASopathies: from pathogenetics to therapeutics.

Authors:  Katie E Hebron; Edjay Ralph Hernandez; Marielle E Yohe
Journal:  Dis Model Mech       Date:  2022-02-18       Impact factor: 5.758

10.  Noonan Syndrome in South Africa: Clinical and Molecular Profiles.

Authors:  Cedrik Tekendo-Ngongang; Gloudi Agenbag; Christian Domilongo Bope; Alina Izabela Esterhuizen; Ambroise Wonkam
Journal:  Front Genet       Date:  2019-04-16       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.